Home / Levosimendan / Czechia
CZ ATC C01CX08 · updated 2 Nov 2026
Levosimendan shortage in Czechia
Is there a Levosimendan shortage in Czechia?
Yes. As of 2 Nov 2026, 2 Levosimendan products are reported short in Czechia, the first since 28 Feb 2024. The company estimate for the return is 1 Apr 2027 (latest 30 Apr 2027). Main reason: commercial decision or withdrawal.
Also short in Italy, Spain, Sweden. All countries.
Affected products in Czechia
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CZ | LEVOSIMENDAN KALCEKS 2,5MG/ML 2,5MG/ML INF CNC SOL 1X5ML | AS Kalceks, Riga | 28 Feb 2024 | 1 Apr 2027 | Commercial decision or withdrawal Obchodní/marketingové důvody |
| CZ | LEVOSIMENDAN FMK 2,5MG/ML 2,5MG/ML INF CNC SOL 1X5ML | FARMAK INTERNATIONAL Sp.z.o.o., Varšava | 20 May 2026 | 30 Apr 2027 | Manufacturing problem Výrobní důvody |
Source
SÚKL (State Institute for Drug Control), market reports. Official list. Products whose latest market report is a supply interruption; one row per SÚKL code.